or
forgot password
  • cancer clinical trials in albuquerque, NM

  • Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    University of New Mexico Cancer Center

    Trial Locations
    University of New Mexico Cancer Center
    Lovelace Medical Center - Downtown
    Prostate Cancer
    Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
    University of New Mexico Cancer Center
    Albuquerque, New Mexico 87131-5636
    Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma, Adult Epithelioid Sarcoma, Adult Extraskeletal Chondrosarcoma, Adult Extraskeletal Osteosarcoma, Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Liposarcoma, Adult Malignant Fibrous Histiocytoma, Adult Malignant Hemangiopericytoma, Adult Malignant Mesenchymoma, Adult Neurofibrosarcoma, Adult Synovial Sarcoma, Childhood Alveolar Soft-part Sarcoma, Childhood Angiosarcoma, Childhood Epithelioid Sarcoma, Childhood Fibrosarcoma, Childhood Leiomyosarcoma, Childhood Liposarcoma, Childhood Malignant Mesenchymoma, Childhood Neurofibrosarcoma, Childhood Synovial Sarcoma, Chondrosarcoma, Dermatofibrosarcoma Protuberans, Localized Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
    University of New Mexico Cancer Center
    Albuquerque, New Mexico 87131-5636
    Adult Malignant Mesenchymoma, Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Childhood Malignant Mesenchymoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
    University of New Mexico Cancer Center
    Albuquerque, New Mexico 87131-5636
    Leukemia, Myelodysplastic Syndromes
    Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia
    University of New Mexico Cancer Center
    Albuquerque, New Mexico 87131-5636
    Leukemia
    Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
    University of New Mexico Cancer Center
    Albuquerque, New Mexico 87131-5636
    Stage III Wilms Tumor, Stage IV Wilms Tumor
    S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy
    University of New Mexico Cancer Center

    Trial Locations
    University of New Mexico Cancer Center
    Lovelace Medical Center - Downtown
    Hematology Oncology Associates, PC
    Presbyterian Cancer Treatment Center at Presbyterian Kaseman Hospital
    Breast Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Hematology Oncology Associates, PC

    Trial Locations
    Hematology Oncology Associates, PC
    New Mexico Cancer Center
    Breast Cancer
    Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
    University of New Mexico Cancer Center
    Albuquerque, New Mexico 87131-5636
    Untreated Childhood Medulloblastoma, Untreated Childhood Pineoblastoma, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
    University of New Mexico Cancer Center
    Albuquerque, New Mexico 87131-5636
    Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, T-cell Adult Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone
    University of New Mexico Cancer Center

    Trial Locations
    University of New Mexico Cancer Center
    Lovelace Medical Center - Downtown
    Hematology Oncology Associates, PC
    Breast Cancer, Metastatic Cancer
    Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
    Hematology Oncology Associates, PC

    Trial Locations
    Hematology Oncology Associates, PC
    Presbyterian Cancer Treatment Center at Presbyterian Kaseman Hospital
    Prostate Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Presbyterian Kaseman Hospital
    Albuquerque, New Mexico 87110
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
    University of New Mexico Cancer Center
    Albuquerque, New Mexico 87131-5636
    Cognitive/Functional Effects, Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment
    Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
    University of New Mexico Cancer Center
    Albuquerque, New Mexico 87131-5636
    Ototoxicity, Unspecified Childhood Solid Tumor, Protocol Specific
    VEGF Trap in Treating Patients With Recurrent or Persistent Endometrial Cancer
    University of New Mexico

    Trial Locations
    University of New Mexico
    Southwest Gynecologic Oncology Associates Inc
    Recurrent Endometrial Carcinoma
    Inflammatory Breast Cancer (IBC) Registry
    University of New Mexico

    Trial Locations
    University of New Mexico
    Univeristy of New Mexico
    Breast Cancer
    Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
    University of New Mexico Cancer Center

    Trial Locations
    University of New Mexico Cancer Center
    Southwest Gynecologic Oncology Associates Inc
    Endometrial Cancer
    Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery
    Presbyterian Kaseman Hospital
    Albuquerque, New Mexico 87110
    HER2-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
    University of New Mexico Cancer Center
    Albuquerque, New Mexico 87131-5636
    Leukemia
    Second Curettage in Treating Patients With Persistent Non-Metastatic Gestational Trophoblastic Tumor
    University of New Mexico Cancer Center
    Albuquerque, New Mexico 87131-5636
    Gestational Trophoblastic Tumor
    Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone
    University of New Mexico
    Albuquerque, New Mexico 87131
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
    University of New Mexico Cancer Center
    Albuquerque, New Mexico 87131-5636
    Leukemia
    Efficacy Study of ABR-215050 to Treat Prostate Cancer
    Urology Group of New Mexico
    Albuquerque, New Mexico 87109
    Prostate Cancer
    Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
    University of New Mexico Cancer Center

    Trial Locations
    University of New Mexico Cancer Center
    Southwest Gynecologic Oncology Associates Inc
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
    Radiation Oncology Associates, PA
    Albuquerque, New Mexico 87109
    Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    University of New Mexico Cancer Center
    Albuquerque, New Mexico 87131-5636
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
    University of New Mexico Cancer Center
    Albuquerque, New Mexico 87131-5636
    B-cell Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia
    Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLC
    New Mexico Oncology Hematology Consultants
    Albuquerque, New Mexico 87102
    Non-Small Cell Lung Cancer
    Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer
    Research Site
    Albuquerque, New Mexico
    Metastatic Colorectal Cancer, Colon Cancer, Colorectal Cancer, Rectal Cancer
    Evaluation of Programs of Coordinated Care and Disease Management
    Lovelace Health Systems
    Albuquerque, New Mexico 87108
    Congestive Heart Failure, Diabetes, Coronary Artery Disease, Chronic Obstructive Pulmonary Disease, Cancer, Cerebrovascular Disease, Alzheimer's Disease, Psychotic Disorder, Major Depression
    Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma
    University of New Mexico Cancer Center
    Albuquerque, New Mexico 87131-5636
    High Risk Stage III Melanoma